Vincerx Pharma Plans Delisting After Nasdaq Suspends Trading

MT Newswires Live

Apr 18

Vincerx Pharma (VINC) said late Thursday it plans to file a delisting form with the Securities and Exchange Commission on or about April 28 to have its common stock removed from Nasdaq.

The decision comes after Vincerx was issued a noncompliance notice from Nasdaq for failing to meet the minimum $1.00 bid price requirement for 30 consecutive business days without any period to regain compliance, the company said.

Nasdaq suspended trading of the company's common shares on April 16 despite notifying it would do so on April 23, it added.

Vincerx said it worked with Nasdaq to allow trading to resume on Monday, and trading will be permanently suspended at the open of business on April 23.

The company said it will file Form 15 to deregister with the SEC once the delisting application comes into effect.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2528795347"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2528795347\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2528795347?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-18 05:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2528795347","market":"nz","top_or_hot":-1,"title":"Vincerx Pharma Plans Delisting After Nasdaq Suspends Trading","media":"MT Newswires Live","content":"<html><body><p> Vincerx Pharma (VINC) said late Thursday it plans to file a delisting form with the Securities and Exchange Commission on or about April 28 to have its common stock removed from Nasdaq.</p><p>The decision comes after Vincerx was issued a noncompliance notice from Nasdaq for failing to meet the minimum $1.00 bid price requirement for 30 consecutive business days without any period to regain compliance, the company said.</p><p>Nasdaq suspended trading of the company's common shares on April 16 despite notifying it would do so on April 23, it added.</p><p>Vincerx said it worked with Nasdaq to allow trading to resume on Monday, and trading will be permanently suspended at the open of business on April 23.</p><p>The company said it will file Form 15 to deregister with the SEC once the delisting application comes into effect.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vincerx Pharma Plans Delisting After Nasdaq Suspends Trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVincerx Pharma Plans Delisting After Nasdaq Suspends Trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-04-18 05:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Vincerx Pharma (VINC) said late Thursday it plans to file a delisting form with the Securities and Exchange Commission on or about April 28 to have its common stock removed from Nasdaq.</p><p>The decision comes after Vincerx was issued a noncompliance notice from Nasdaq for failing to meet the minimum $1.00 bid price requirement for 30 consecutive business days without any period to regain compliance, the company said.</p><p>Nasdaq suspended trading of the company's common shares on April 16 despite notifying it would do so on April 23, it added.</p><p>Vincerx said it worked with Nasdaq to allow trading to resume on Monday, and trading will be permanently suspended at the open of business on April 23.</p><p>The company said it will file Form 15 to deregister with the SEC once the delisting application comes into effect.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2210150020.SGD","symbol_name":"Natixis Thematics Subscription Economy R/A SGD","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2528795347","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2528795347","pubTimestamp":1744924071,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Vincerx Pharma  said late Thursday it plans to file a delisting form with the Securities and Exchange Commission on or about April 28 to have its common stock removed from Nasdaq.The decision comes after Vincerx was issued a noncompliance notice from Nasdaq for failing to meet the minimum $1.00 bid price requirement for 30 consecutive business days without any period to regain compliance, the company said.Nasdaq suspended trading of the company's common shares on April 16 despite notifying it would do so on April 23, it added.Vincerx said it worked with Nasdaq to allow trading to resume on Monday, and trading will be permanently suspended at the open of business on April 23.The company said it will file Form 15 to deregister with the SEC once the delisting application comes into effect.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU2210150020.SGD":"Natixis Thematics Subscription Economy R/A SGD",".IXIC":"NASDAQ Composite","IE00B3QW5Z07.USD":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (USD) ACC","VINC":"Vincera Pharma, Inc.","IE00BKPKM429.USD":"NEUBERGER BERMAN GLOBAL SUSTAINABLE EQUITY \"A\" (USD) ACC","BK4588":"碎股","BK4585":"ETF&股票定投概念","BK4112":"金融交易所和数据","LU2095319765.USD":"Natixis Thematics Subscription Economy R/A USD","IE00BGHQF748.EUR":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (EUR) ACC","BK4139":"生物科技","NDAQ":"纳斯达克OMX交易所","IE00B64PRP62.GBP":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (GBP) ACC","LU2210149790.SGD":"Natixis Thematics Subscription Economy R/A SGD-H"},"translate_title":"纳斯达克停牌后Vincerx Pharma计划退市","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NQmain":1,"VINC":0.9,"NDAQ":1,".IXIC":1},"content_text":"Vincerx Pharma (VINC) said late Thursday it plans to file a delisting form with the Securities and Exchange Commission on or about April 28 to have its common stock removed from Nasdaq.The decision comes after Vincerx was issued a noncompliance notice from Nasdaq for failing to meet the minimum $1.00 bid price requirement for 30 consecutive business days without any period to regain compliance, the company said.Nasdaq suspended trading of the company's common shares on April 16 despite notifying it would do so on April 23, it added.Vincerx said it worked with Nasdaq to allow trading to resume on Monday, and trading will be permanently suspended at the open of business on April 23.The company said it will file Form 15 to deregister with the SEC once the delisting application comes into effect.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}